NO305984B1 - Farmasoeytisk preparat aktivt mot HIV, sammenknyttet cykliske forbindelser og fremstilling derav - Google Patents

Farmasoeytisk preparat aktivt mot HIV, sammenknyttet cykliske forbindelser og fremstilling derav

Info

Publication number
NO305984B1
NO305984B1 NO942254A NO942254A NO305984B1 NO 305984 B1 NO305984 B1 NO 305984B1 NO 942254 A NO942254 A NO 942254A NO 942254 A NO942254 A NO 942254A NO 305984 B1 NO305984 B1 NO 305984B1
Authority
NO
Norway
Prior art keywords
preparation
active against
atoms
cyclic compounds
against hiv
Prior art date
Application number
NO942254A
Other languages
English (en)
Norwegian (no)
Other versions
NO942254L (no
NO942254D0 (no
Inventor
Gary James Bridger
Sreenivasan Padmanabhan
Renato Tony Skerlj
David Michael Thornton
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10706343&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO305984(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Anormed Inc filed Critical Anormed Inc
Publication of NO942254L publication Critical patent/NO942254L/no
Publication of NO942254D0 publication Critical patent/NO942254D0/no
Publication of NO305984B1 publication Critical patent/NO305984B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Liquid Crystal Substances (AREA)
  • Furan Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO942254A 1991-12-16 1994-06-15 Farmasoeytisk preparat aktivt mot HIV, sammenknyttet cykliske forbindelser og fremstilling derav NO305984B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919126677A GB9126677D0 (en) 1991-12-16 1991-12-16 Improvements in chemical compounds
PCT/GB1992/002334 WO1993012096A1 (en) 1991-12-16 1992-12-16 Linked cyclic polyamines with activity against hiv

Publications (3)

Publication Number Publication Date
NO942254L NO942254L (no) 1994-06-15
NO942254D0 NO942254D0 (no) 1994-06-15
NO305984B1 true NO305984B1 (no) 1999-08-30

Family

ID=10706343

Family Applications (2)

Application Number Title Priority Date Filing Date
NO942254A NO305984B1 (no) 1991-12-16 1994-06-15 Farmasoeytisk preparat aktivt mot HIV, sammenknyttet cykliske forbindelser og fremstilling derav
NO2010001C NO2010001I2 (no) 1991-12-16 2010-02-04 1,1'-[1,4-fenylenbis(metylen)]-bis-1,4,8,11-tetraazacyclotetradecan

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2010001C NO2010001I2 (no) 1991-12-16 2010-02-04 1,1'-[1,4-fenylenbis(metylen)]-bis-1,4,8,11-tetraazacyclotetradecan

Country Status (26)

Country Link
US (2) US5583131A (ja)
EP (2) EP1223166A1 (ja)
JP (1) JP3375961B2 (ja)
KR (1) KR100286235B1 (ja)
AT (1) ATE273964T1 (ja)
AU (1) AU661086B2 (ja)
CA (1) CA2125978C (ja)
CZ (1) CZ286928B6 (ja)
DE (2) DE69233401T2 (ja)
DK (1) DK0619813T3 (ja)
ES (1) ES2224096T3 (ja)
FI (1) FI942849A (ja)
GB (1) GB9126677D0 (ja)
HK (2) HK1014368A1 (ja)
HU (1) HU224013B1 (ja)
IL (1) IL103984A (ja)
MX (1) MX9207316A (ja)
MY (1) MY110897A (ja)
NL (1) NL300425I1 (ja)
NO (2) NO305984B1 (ja)
NZ (1) NZ246179A (ja)
PL (1) PL173643B1 (ja)
PT (1) PT619813E (ja)
RU (1) RU94031208A (ja)
WO (1) WO1993012096A1 (ja)
ZA (1) ZA929632B (ja)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9126677D0 (en) 1991-12-16 1992-02-12 Johnson Matthey Plc Improvements in chemical compounds
GB9318550D0 (en) * 1993-09-07 1993-10-20 Nycomed Salutar Inc Chelants
GB9400411D0 (en) * 1994-01-11 1994-03-09 Johnson Matthey Plc Improvements in chemical compounds
US5663161A (en) * 1995-02-17 1997-09-02 The Research Foundation Of State University Of New York Anti-viral triaza compounds
US5612478A (en) * 1995-03-30 1997-03-18 Johnson Matthey Plc Process for preparing 1,1'-[1,4-phenylenebis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane
US5606053A (en) * 1995-05-02 1997-02-25 Johnson Matthey Plc Process for preparing 1,1'-[1,4-phenylenebis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane
US6506770B1 (en) * 1996-06-06 2003-01-14 Anormed, Inc. Antiviral compounds
GB9511357D0 (en) * 1995-06-06 1995-08-02 Johnson Matthey Plc Improved antiviral compounds
US5608061A (en) * 1995-08-02 1997-03-04 Johnson Matthey Plc Process for preparing 1,4,8,11-tetraazacyclotetradecane
US7087648B1 (en) * 1997-10-27 2006-08-08 The Regents Of The University Of California Methods for modulating macrophage proliferation using polyamine analogs
DE69929464T2 (de) 1998-11-17 2006-09-07 Smithkline Beecham Corp. Zyklische polyamine zur behandlung der thrombozytopenie
US6365583B1 (en) 1999-02-02 2002-04-02 Anormed, Inc. Methods to enhance white blood cell count
US6750348B1 (en) 1999-03-24 2004-06-15 Anormed, Inc. Chemokine receptor binding heterocyclic compounds
MXPA01009674A (es) * 1999-03-24 2003-07-21 Anormed Inc Compuestos heterociclicos que se unen a receptores de quimiocina.
AU4692400A (en) * 1999-05-03 2000-11-17 Smithkline Beecham Corporation Cxcr-4 receptor antagonists - thrombopoietin mimetics
JP2003516984A (ja) 1999-12-17 2003-05-20 アノーメッド・インコーポレイテッド ケモカインレセプターを結合する複素環式化合物
AU2001233290A1 (en) * 2000-02-22 2001-09-03 Brewer Science, Inc. Organic polymeric antireflective coatings deposited by chemical vapor deposition
NZ524420A (en) * 2000-09-15 2005-04-29 Anormed Inc Chemokine receptor binding heterocyclic compounds
KR20030029997A (ko) * 2000-09-15 2003-04-16 아노르메드 인코포레이티드 케모킨 수용체 결합 헤테로사이클릭 화합물
KR20030034184A (ko) 2000-09-15 2003-05-01 아노르메드 인코포레이티드 케모킨 수용체 결합 헤테로사이클릭 화합물
RU2311413C2 (ru) 2000-09-29 2007-11-27 Анормед, Инк. Циклические полиамины, содержащие в кольце n атомов азота, защищенных по принципу "все, кроме одного (n-1)", и способы их получения
DE10117206A1 (de) * 2001-04-06 2002-10-10 Bayer Ag Verfahren zur Herstellung von halogensubstituierten Dibenzylalkoholen, diese halogensubstituierten Dibenzylalkohole sowie deren Verwendung
MXPA04000982A (es) * 2001-07-31 2004-04-20 Anormed Inc Metodos para movilizar celulas progenitoras/madre.
US7169750B2 (en) * 2001-07-31 2007-01-30 Anormed, Inc. Methods to mobilize progenitor/stem cells
WO2003022785A2 (en) * 2001-09-12 2003-03-20 Anormed Inc. Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
US7354932B2 (en) * 2001-12-21 2008-04-08 Anormed, Inc. Chemokine receptor binding heterocyclic compounds with enhanced efficacy
MXPA04006136A (es) * 2001-12-21 2004-11-01 Anormed Inc Compuestos heterociclicos que se unen a receptor de quimiocina con eficacia incrementada.
ES2610611T3 (es) * 2002-01-18 2017-04-28 Astellas Pharma Inc. Derivado de 2-acilaminotiazol o sal del mismo
CA2520259A1 (en) * 2003-04-11 2004-10-28 Anormed Inc. Cxcr4 chemokine receptor binding compounds
IN266744B (ja) * 2003-04-22 2015-05-29 Genzyme Corp
US7501518B2 (en) * 2003-04-22 2009-03-10 Genzyme Corporation Methods of making 2,6-diaryl piperidine derivatives
US7498346B2 (en) * 2003-12-11 2009-03-03 Genzyme Corporation Chemokine receptor binding compounds
CA2548393A1 (en) * 2003-12-11 2005-06-30 Anormed Inc. Chemokine receptor binding compounds
RU2006136381A (ru) * 2004-03-15 2008-04-27 Анормед, Инк. (Ca) Способ получения антагониста cxcr4
DE602005025497D1 (de) * 2004-08-05 2011-02-03 Sumitomo Chemical Co Verfahren zur herstellung von halogensubstituiertem benzoldimethanol
JP2008509928A (ja) * 2004-08-13 2008-04-03 アノーメド インコーポレイテッド 前駆／幹細胞を動員するためのケモカインの組み合わせ
TW200619206A (en) * 2004-09-29 2006-06-16 Anormed Inc Chemokine-binding heterocyclic compound salts, and methods of use thereof
EP1814587A2 (en) * 2004-11-05 2007-08-08 The General Hospital Corporation Purposeful movement of human migratory cells away from an agent source
EP1942890A4 (en) * 2005-06-15 2009-08-26 Genzyme Corp CHEMOKINE RECEPTOR BINDING COMPOUNDS
US20070066624A1 (en) * 2005-08-16 2007-03-22 Anormed, Inc. Chemokine receptor binding compounds
JP2009504788A (ja) 2005-08-19 2009-02-05 ジェンザイム・コーポレーション 化学療法の強化方法
CA2628848A1 (en) * 2005-11-08 2007-05-18 Astellas Pharma Inc. Compositions and methods for treating thrombocytopenia
WO2007086330A1 (ja) 2006-01-24 2007-08-02 Sumitomo Chemical Company, Limited ハロゲン置換ベンゼンジメタノールの製造法
MX2008010895A (es) * 2006-02-24 2008-09-03 Genzyme Corp Metodos para aumentar el flujo sanguineo y/o promover la regeneracion de tejidos.
RU2009107030A (ru) * 2006-08-02 2010-09-10 Джензим Корпорейшн (Us) Комбинированная терапия
MX2009001445A (es) * 2006-08-07 2009-02-18 Genzyme Corp Terapia de combinacion.
JP2010500361A (ja) * 2006-08-08 2010-01-07 アカークス，インコーポレーテッド ヒトの血小板レベルを増加させるための組成物および方法
US20080214509A1 (en) * 2007-03-02 2008-09-04 Robert Kerbel Methods for enhancing the efficacy of vascular disrupting agents
JP5597129B2 (ja) 2007-06-18 2014-10-01 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド 胎盤由来の幹細胞および前駆体細胞の単離方法
US9822364B2 (en) 2008-03-11 2017-11-21 Yale University Compositions and methods for controlled delivery of inhibitory ribonucleic acids
WO2009114614A2 (en) 2008-03-11 2009-09-17 Yale University Compositions and methods for controlled delivery of inhibitory ribonucleic acids
EP2149567A1 (en) * 2008-07-18 2010-02-03 Bayer Schering Pharma Aktiengesellschaft Cyclic polyamines for binding phosphatidylserine
US8771677B2 (en) * 2008-12-29 2014-07-08 Vladimir B Serikov Colony-forming unit cell of human chorion and method to obtain and use thereof
JP2014513727A (ja) 2011-05-16 2014-06-05 ジェンザイム・コーポレーション Ｃｘｃｒ４拮抗薬の使用
US10465042B2 (en) 2011-12-02 2019-11-05 Yale University Poly(amine-co-ester) nanoparticles and methods of use thereof
WO2013082529A1 (en) 2011-12-02 2013-06-06 Yale University Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery
US9895451B2 (en) 2011-12-02 2018-02-20 Yale University Formulations for targeted release of agents to low pH tissue environments or cellular compartments and methods of use thereof
WO2014125499A1 (en) 2013-02-13 2014-08-21 Natco Pharma Limited Improved and commercially viable process for the preparation of high pure plerixafor base
PT107018A (pt) * 2013-06-20 2014-12-22 Inst Superior Técnico Síntese e uso de ciclamas com atividade antibacteriana
WO2015031722A1 (en) 2013-08-30 2015-03-05 Ramot At Tel-Aviv University Ltd. Method for treating amyotrophic lateral sclerosis by inhibition of cxcr4/cxcl12 signaling
EP3139909A4 (en) 2014-05-09 2018-01-03 Yale University Topical formulation of hyperbranched polyglycerol-coated particles thereof
US11918695B2 (en) 2014-05-09 2024-03-05 Yale University Topical formulation of hyperbranched polymer-coated particles
US10682422B2 (en) 2014-11-18 2020-06-16 Yale University Formulations for targeted release of agents under low pH conditions and methods of use thereof
WO2016081621A1 (en) 2014-11-18 2016-05-26 Yale University Formulations for targeted release of agents under low ph conditions and methods of use thereof
ES2764840T3 (es) 2015-01-28 2020-06-04 Univ Bordeaux Uso de plerixafor para tratar y/o prevenir exacerbaciones agudas de la enfermedad pulmonar obstructiva crónica
RU2017140778A (ru) 2015-04-25 2019-05-27 Дзе Дженерал Хоспитал Корпорейшн Комбинированная терапия антифугетактическим средством и противораковым средством, и композиции для лечения рака
WO2016191811A1 (en) 2015-06-03 2016-12-08 The University Of Queensland Mobilizing agents and uses therefor
WO2017037639A1 (en) 2015-09-02 2017-03-09 Fresenius Kabi Oncology Ltd. A process for the preparation of xylene linked cyclam compounds
CA2999083A1 (en) 2015-09-18 2017-03-23 The General Hospital Corporation Dba Massachusetts General Hospital Localized delivery of anti-fugetactic agent for treatment of cancer
WO2017106332A1 (en) 2015-12-14 2017-06-22 X4 Pharmaceuticals, Inc. Methods for treating cancer
CN109069426B (zh) 2015-12-14 2021-10-29 X4 制药有限公司 治疗癌症的方法
US11433136B2 (en) 2015-12-18 2022-09-06 The General Hospital Corporation Polyacetal polymers, conjugates, particles and uses thereof
DK3393468T3 (da) 2015-12-22 2022-12-19 X4 Pharmaceuticals Inc Fremgangsmåder til behandling af en immundefektsygdom
US11136597B2 (en) 2016-02-16 2021-10-05 Yale University Compositions for enhancing targeted gene editing and methods of use thereof
AU2017221424A1 (en) 2016-02-16 2018-09-20 Yale University Compositions and methods for treatment of cystic fibrosis
JP2019510785A (ja) 2016-04-08 2019-04-18 エックス４ ファーマシューティカルズ， インコーポレイテッド 癌を処置する方法
WO2017197128A1 (en) 2016-05-11 2017-11-16 Yale University Poly(amine-co-ester) nanoparticles and methods of use thereof
US11332470B2 (en) 2016-06-21 2022-05-17 X4 Pharmaceuticals, Inc. CXCR4 inhibitors and uses thereof
ES2870920T3 (es) 2016-06-21 2021-10-28 X4 Pharmaceuticals Inc Inhibidores de CXCR4 y usos de los mismos
JP7084624B2 (ja) 2016-06-21 2022-06-15 エックス４ ファーマシューティカルズ， インコーポレイテッド Ｃｘｃｒ４阻害剤およびその使用
US11453706B2 (en) 2016-09-09 2022-09-27 The General Hospital Corporation HSP fusion protein with anti-chemorepellant agent for treatment of infectious disease
EP3509609A4 (en) 2016-09-09 2021-01-20 The General Hospital Corporation HYBRID HSP PROTEIN WITH ANTI-CHEMIO-REPELLENT AGENT FOR CANCER TREATMENT
WO2018049120A1 (en) 2016-09-09 2018-03-15 The General Hospital Corporation Ex vivo antigen-presenting cells or activated cd-positive t cells for treatment of cancer
WO2018053270A1 (en) 2016-09-16 2018-03-22 The General Hospital Corporation Modified natural killer cells for the treatment of cancer
WO2018106738A1 (en) 2016-12-05 2018-06-14 Massachusetts Institute Of Technology Brush-arm star polymers, conjugates and particles, and uses thereof
JP2020515542A (ja) 2017-03-23 2020-05-28 ザ ジェネラル ホスピタル コーポレイション Ｃｘｃｒ４／ｃｘｃｒ７の遮断およびヒトパピローマウイルス関連疾患の治療
WO2018187493A1 (en) 2017-04-04 2018-10-11 Yale University Compositions and methods for in utero delivery
EP3704232A1 (en) 2017-10-31 2020-09-09 Magenta Therapeutics, Inc. Compositions and methods for the expansion of hematopoietic stem and progenitor cells
JP2021503008A (ja) 2017-10-31 2021-02-04 マジェンタ セラピューティクス インコーポレイテッドＭａｇｅｎｔａ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． 造血幹細胞および前駆細胞移植療法のための組成物および方法
MX2020005878A (es) 2017-12-06 2020-10-07 Magenta Therapeutics Inc Pautas posológicas para la movilización de células madre y progenitoras hematopoyéticas.
US10058573B1 (en) 2017-12-06 2018-08-28 Magenta Therapeutics, Inc. Dosing regimens for the mobilization of hematopoietic stem cells
US11260079B2 (en) 2017-12-06 2022-03-01 Magenta Therapeutics, Inc. Dosing regimens for the mobilization of hematopoietic stem and progenitor cells
WO2019136159A1 (en) 2018-01-03 2019-07-11 Magenta Therapeutics Inc. Compositions and methods for the expansion of hematopoietic stem and progenitor cells and treatment of inherited metabolic disorders
WO2020033951A1 (en) 2018-08-10 2020-02-13 Yale University Compositions and methods for embryonic gene editing in vitro
US10548889B1 (en) 2018-08-31 2020-02-04 X4 Pharmaceuticals, Inc. Compositions of CXCR4 inhibitors and methods of preparation and use
US11814464B2 (en) 2019-04-29 2023-11-14 Yale University Poly(amine-co-ester) polymers and polyplexes with modified end groups and methods of use thereof
WO2020257776A1 (en) 2019-06-21 2020-12-24 Yale University Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
US20220372474A1 (en) 2019-06-21 2022-11-24 Yale University Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
WO2021022161A1 (en) 2019-07-31 2021-02-04 Yale University Compositions and methods for treating sickle cell disease
WO2021087406A1 (en) 2019-11-01 2021-05-06 Magenta Therapeutics, Inc. Dosing regimens for the mobilization of hematopoietic stem and progentor cells
EP4143302A1 (en) 2020-04-27 2023-03-08 Magenta Therapeutics, Inc. Methods and compositions for transducing hematopoietic stem and progenitor cells in vivo
EP4168471A1 (en) 2020-06-19 2023-04-26 Yale University Poly(amine-co-ester) polymers with modified end groups and enhanced pulmonary delivery
US20220031633A1 (en) 2020-07-28 2022-02-03 Yale University Poly(amine-co-ester) polymeric particles for selective pulmonary delivery
WO2022197776A1 (en) 2021-03-16 2022-09-22 Magenta Therapeutics, Inc. Dosing regimens for hematopoietic stem cell mobilization for stem cell transplants in multiple myeloma patients
US20230104658A1 (en) 2021-10-01 2023-04-06 Janssen Pharmaceutica Nv Methods of increasing progenitor cell production
US20230172870A1 (en) 2021-12-08 2023-06-08 Yale University Surface conjugation to poly(amine-co-ester) nanoparticles for targeting to cells and tissues
WO2023159189A1 (en) 2022-02-18 2023-08-24 Yale University Branched poly(amine-co-ester) polymers for more efficient nucleic expression

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994560A (en) 1987-06-24 1991-02-19 The Dow Chemical Company Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies
DE3728525A1 (de) * 1987-08-24 1989-03-16 Schering Ag Mehrkernige substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
US5047572A (en) * 1988-11-18 1991-09-10 Ici Americas Inc. Trisubstituted benzoic acid intermediates
FR2644453A1 (fr) 1989-03-20 1990-09-21 Centre Nat Rech Scient Procede de preparation de tetramines cycliques monofonctionnalisees
CA2069886A1 (en) * 1989-10-23 1991-04-24 David Love Multi-site metal chelating agents
US5021409A (en) * 1989-12-21 1991-06-04 Johnson Matthey Plc Antiviral cyclic polyamines
FR2672051B1 (fr) 1991-01-24 1993-05-21 Guerbet Sa Nouveaux ligands macrocycliques azotes, procede de preparation, complexes polymetalliques, composition de diagnostic et therapeutique.
GB9105489D0 (en) * 1991-03-15 1991-05-01 Johnson Matthey Plc Improvements in chemical compounds
GB9126677D0 (en) 1991-12-16 1992-02-12 Johnson Matthey Plc Improvements in chemical compounds

Also Published As

Publication number Publication date
NO942254L (no) 1994-06-15
HU224013B1 (hu) 2005-04-28
AU661086B2 (en) 1995-07-13
HK1014368A1 (en) 1999-09-24
RU94031208A (ru) 1996-09-10
NO2010001I2 (no) 2012-08-27
GB9126677D0 (en) 1992-02-12
EP0619813A1 (en) 1994-10-19
NZ246179A (en) 1996-03-26
HK1049328A1 (zh) 2003-05-09
KR100286235B1 (ko) 2001-04-16
CZ118894A3 (en) 1995-10-18
DK0619813T3 (da) 2004-12-20
PT619813E (pt) 2004-12-31
NO942254D0 (no) 1994-06-15
WO1993012096A1 (en) 1993-06-24
HUT67544A (en) 1995-04-28
AU3165593A (en) 1993-07-19
CA2125978C (en) 2005-09-20
PL173643B1 (pl) 1998-04-30
USRE42152E1 (en) 2011-02-15
CA2125978A1 (en) 1993-06-24
ES2224096T3 (es) 2005-03-01
JPH07501816A (ja) 1995-02-23
ZA929632B (en) 1993-06-18
IL103984A (en) 1998-10-30
EP1223166A1 (en) 2002-07-17
NO2010001I1 (no) 2010-03-08
HU9401786D0 (en) 1994-09-28
FI942849A0 (fi) 1994-06-15
CZ286928B6 (cs) 2000-08-16
MY110897A (en) 1999-06-30
US5583131A (en) 1996-12-10
NL300425I1 (nl) 2010-01-04
IL103984A0 (en) 1993-05-13
DE69233401T2 (de) 2005-10-13
MX9207316A (es) 1993-06-01
EP0619813B1 (en) 2004-08-18
FI942849A (fi) 1994-06-15
DE122010000001I1 (de) 2010-08-26
JP3375961B2 (ja) 2003-02-10
DE69233401D1 (de) 2004-09-23
ATE273964T1 (de) 2004-09-15

Similar Documents

Publication Publication Date Title
NO305984B1 (no) Farmasoeytisk preparat aktivt mot HIV, sammenknyttet cykliske forbindelser og fremstilling derav
NO933376L (no) Morfinan-derivater og medisinsk anvendelse derav
ZA9010184B (en) Anti-viral compositions containing linked polyamines
BR9206623A (pt) Uréias cíclicas e análogas úteis como inibidoras da protease retroviral
CA2179530A1 (en) Cyclic polyamines
DE68905407D1 (de) Analgetische carbonsaeureamid-derivate.
NO941451D0 (no) Oksazolinderivat
KR910000645A (ko) 개선된 경련치료제
ES351470A1 (es) Un procedimiento de sintesis de nuevas 2-arilalcohiloxi- benzamidas.
GB1377449A (en) N,n-bridged-bis-2-alkyl-2-hydroxy ethylamine compounds
GB1470259A (en) 3,5-dimethylbenzoic acid derivatives
TH3422A (th) สารประกอบ

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: MOZOBIL-PLERIXAFOR; NAT. REG. NO/DATE: EU/1/09/537/001/NO 20090810; FIRST REG. NO/DATE: EU/1/09/537/001 20090731

Spc suppl protection certif: 2010001

Filing date: 20100204

SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: MOZOBIL-PLERIXAFOR; NAT. REG. NO/DATE: EU/1/09/537/001/NO 20090810; FIRST REG. NO/DATE: EU/1/09/537/001 20090731

Spc suppl protection certif: 2010001

Filing date: 20100204

Extension date: 20171216

MK1K Patent expired
SPCW Withdrawal, rejection or dismissal of supplementary protection certificate

Spc suppl protection certif: 2010001